Company Quick10K Filing
Acro Biomedical
10-Q 2020-03-31 Filed 2020-05-19
10-K 2019-09-30 Filed 2020-01-07
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-02-14
10-K 2018-09-30 Filed 2018-12-28
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-08-01
S-1 2018-02-15 Public Filing
10-Q 2017-12-31 Filed 2018-02-14
10-K 2017-09-30 Filed 2018-01-16
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-22
10-Q 2016-12-31 Filed 2017-02-14
10-K 2016-09-30 Filed 2016-12-16
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-13
8-K 2020-01-13
8-K 2018-10-18
8-K 2018-07-06
8-K 2018-06-19

Acro Biomedical Financials

ACBM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Union Bridge Holdings (UGHL) 188,095 26% -422.5 -815% 55 977 65 17 -445 -445 188,075
IDEAYA Biosciences (IDYA) 186,410 -3.7 -18% 122,331 11,925 0 0 -21,625 -21,025 77,010
GrowGeneration (GRWG) 182,705 29% 57.2 3% 68,417 15,626 54,349 16,008 2,341 2,923 167,194
Technovative Group (TEHG) 182,172 57% -105.6 -33% 5,191 3,101 765 437 -1,719 -1,719 181,597
Exagen (XGN) 182,113 54% -60.9 -3% 92,744 34,094 10,439 5,656 -3,141 -2,132 129,862
Soliton (SOLY) 179,964 -14.9 -130% 9,927 2,745 0 0 -12,896 -11,529 171,255
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420
SWK Holdings (SWKH) 167,159 0% 9.7 6% 247,535 19,907 21,396 0 15,043 16,831 162,673
DOCASA (DCSA) 166,631 24% -117.8 -8% 22,047 6,626 6,454 1,527 -1,773 -1,408 165,842

Balance Sheet ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash8232009472513800
Accounts Receivable
Inventory7163019001,1473601,0601,060
PP&E
Assets12232227658681,0101,4831,2711,1391,081
Accounts Payable311
Long-Term Debt
Liabilities31117251831173207233241103141133
Stockholders' Equity8-9-15-22-16-285926617771,2421,168998948
Income Statement ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue000001,4451,9642,1992,4061,35400
Cost of Revenue1,3001,7681,9592,1541,21900
Gross Profit14419624025313500
R&D
SG&A001010698649223021568
Tax000000296000019
Net Income-6-17-6-7-22-128069116154-75-170-51
Cash Flow ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-6-10-0-29-18-28404-4174-52-85
Cash Investing000
Cash Financing027181-1381585